Diagnosis of adult GH deficiency

Pituitary

Volumn 11, Issue 2, 2008, Pages 121-128

  Gasco, V ^a   Corneli, G ^b   Rovere, S ^a   Croce, C ^a   Beccuti, G ^a   Mainolfi, A ^a   Grottoli, S ^a   Aimaretti, G ^b   Ghigo, Ezio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Adult GH deficiency; Diagnosis; GH; IGF I

Indexed keywords

ARGININE; GHRELIN; GLUCAGON; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE SECRETAGOGUE; HEXARELIN; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; PRALMORELIN; SOMATOMEDIN C;

ARTICLE; BRAIN TUMOR; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GOLD STANDARD; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HYPOPITUITARISM; INSULIN TOLERANCE TEST; INTERMETHOD COMPARISON; LEAN BODY WEIGHT; LEUKEMIA; LOW DRUG DOSE; MEDULLOBLASTOMA; OBESITY; PHARMACOLOGICAL STIMULATION; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELIABILITY; REPRODUCIBILITY; ROC CURVE; SENSITIVITY AND SPECIFICITY; SKULL IRRADIATION;

ADULT; HUMAN GROWTH HORMONE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; OBESITY; PITUITARY FUNCTION TESTS;

EID: 43049176666     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-008-0110-x     Document Type: Article

References (55)

1. Colao A (1999) The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. J Clin Endocrinol Metab 84:1277-1282. doi: 10.1210/jc.84.4.1277
2. Colao A (1999) Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 84:1919-1924. doi: 10.1210/jc.84.6.1919
3. Colao A (2004) The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: An observational, case-control study. J Clin Endocrinol Metab 89:5998-6004. doi: 10.1210/jc.2004-1042
4. Growth Hormone Research Society (1998) Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency. J Clin Endocrinol Metab 83:379-381. doi: 10.1210/jc.83.2.379
5. Molitch ME (2006) Evaluation and treatment of adult growth hormone deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 91:1621-1634. doi: 10.1210/jc.2005-2227
6. Aimaretti G (1998) Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults. J Endocrinol Invest 21:506-511
7. Ghigo E (2001) Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. Endocrine 15:29-38. doi: 10.1385/ENDO:15:1:029
8. Gharib H (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children-2003 update. Endocr Pract 9:64-76
9. Aimaretti G (2003) Diagnostic reliability of a single IGF-I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency. Clin Endocrinol (Oxf) 59:56-61. doi: 10.1046/ j.1365-2265.2003.01794.x
10. Hartman ML (2002) Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 87:477-485. doi: 10.1210/jc.87.2.477
11. Attanasio AF (1997) Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab 82:82-88. doi: 10.1210/jc.82.1.82
12. Aimaretti G (2005) Different degrees of GH deficiency evidenced by GHRH-arginine test and IGF-I levels in adults with pituitary disease. J Endocrinol Invest 28:247-252
13. Hilding A (1999) Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 84:2013-2019. doi: 10.1210/jc.84.6.2013
14. Granada ML (2000) Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: Importance of an appropriate reference population. Eur J Endocrinol 142:243-253. doi: 10.1530/eje.0.1420243
15. Boquete HR (2003) Evaluation of diagnostic accuracy of insulin-like growth factor IGF)-I and IGF-binding protein-3 in growth hormone-deficient children and adults using ROC plot analysis. J Clin Endocrinol Metab 88:4702-4708. doi: 10.1210/jc.2003-030412
16. Ho KKY (2007) Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency II. Eur J Endocrinol 157:695-700
17. Jones SL (1994) An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol (Oxf) 41:123-128
18. Hoeck HC (1995) Test of growth hormone secretion in adults: Poor reproducibility of the insulin tolerance test. Eur J Endocrinol 133:305-312
19. Vestergaard P (1997) Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults. Horm Metab Res 29:106-110
20. Ghigo E (2008) Diagnosis of adult GH deficiency. Growth Horm IGF Res 18:1-16
21. Aimaretti G (2000) Comparisons among old and new provocative tests of GH secretion in 178 normal adults. Eur J Endocrinol 142:347-352. doi: 10.1530/eje.0.1420347
22. Biller BM (2002) Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 87:2067-2079. doi: 10.1210/jc.87.5.2067
23. Hoffman DM (1994) Diagnosis of growth hormone deficiency in adults. Lancet 343:1064-1068. doi: 10.1016/S0140-6736(94)90181-3
24. Ghigo E (1992) Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. Metabolism 41:560-563. doi: 10.1016/0026-0495(92)90220-5
25. Procopio M (1995) Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine. Clin Endocrinol (Oxf) 43:665-669
26. Maccario M (1999) Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test. J Endocrinol Invest 22:424-429
27. Maccario M (2001) Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. Int J Obes Relat Metab Disord 25:1233-1239. doi: 10.1038/sj.ijo.0801671
28. Cordido F (2003) Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. Eur J Endocrinol 149:117-122. doi: 10.1530/eje.0.1490117
29. Bonert VS (2004) Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: Diagnostic caveat for adult GH deficiency. J Clin Endocrinol Metab 89:3397-3401. doi: 10.1210/ jc.2003-032213
30. Qu XD (2005) Influence of body mass index and gender or growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests. J Clin Endocrinol Metab 90:1563-1569. doi: 10.1210/ jc.2004-1450
31. Haijma SV (2005) The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men. Eur J Endocrinol 152:575-580. doi: 10.1530/eje.1.01887
32. Kelestimur F (2006) Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP-6 test. Clin Endocrinol (Oxf) 64:667-671. doi: 10.1111/j.1365-2265.2006.02525.x
33. Gomez JM (2002) Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clin Endocrinol (Oxf) 56:329-334. doi: 10.1046/j.1365-2265.2002.01472.x
34. Conceicao FL (2003) Glucagon stimulation test for the diagnosis of GH deficiency in adults. J Endocrinol Invest 26:1065-1070
35. Aimaretti G (1998) Comparison between insulin-induced hypo-glycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 83:1615-1618. doi: 10.1210/jc.83.5.1615
36. Aimaretti G (2000) Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test. J Clin Endocrinol Metab 85:3693-3699. doi: 10.1210/jc.85.10.3693
37. Aimaretti G (2001) Short procedure of GHRH plus arginine test in clinical practice. Pituitary 4:129-134. doi: 10.1023/A:1015306705154
38. Popovic V (2004) Evaluation of the reproducibility of the GHRH plus GHRP-6 test of growth hormone reserve in adults. Clin Endocrinol (Oxf) 60:185-191. doi: 10.1046/j.1365-2265.2003.01955.x
39. Cordido F (1993) Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab 76:819-823. doi: 10.1210/jc.76.4.819
40. Gasperi M (1999) Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: Comparison with insulin-induced hypoglycemia test. J Clin Endocrinol Metab 84:2633-2637. doi: 10.1210/jc.84.8.2633
41. Mahajan T (2000) A simple test for growth hormone deficiency in adults. J Clin Endocrinol Metab 85:1473-1476. doi: 10.1210/jc.85.4.1473
42. Aimaretti G (2002) Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency. Clin Endocrinol (Oxf) 56:765-771. doi: 10.1046/j.1365-2265.2002.01547.x
43. Popovic V (2000) GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet 356:1137-1142. doi: 10.1016/S0140-6736(00)02755-0
44. Popovic V (2003) The effectiveness of arginine + GHRH test compared with GHRH + GHRP-6 test in diagnosing growth hormone deficiency in adults. Clin Endocrinol (Oxf) 59:251-257. doi: 10.1046/j.1365-2265.2003.01835.x
45. Leal A (2002) A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test. Clin Endocrinol (Oxf) 57:377-384. doi: 10.1046/j.1365-2265.2002.01623.x
46. Popovic V (2002) The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6. J Clin Endocrinol Metab 87:2095-2099. doi: 10.1210/jc.87.5.2095
47. Darzy KH (2003) The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab 88:95-102. doi: 10.1210/ jc.2002-021094
48. Maghnie M (2001) Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism. J Clin Endocrinol Metab 86:1574-1579. doi: 10.1210/ jc.86.4.1574
49. Maghnie M (2008) GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset. J Clin Endocrinol Metab 87:2740-2744. doi: 10.1210/jc.87.6.2740
50. Ham JN (2005) Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy. Clin Endocrinol (Oxf) 62:628-632. doi: 10.1111/ j.1365-2265.2005.02272.x
51. Bjork J (2005) The utility of the growth hormone (GH) releasing hormone-arginine test for diagnosing GH deficiency in adults with childhood acute lymphoblastic leukaemia treated with cranial irradiation. J Clin Endocrinol Metab 90:6048-6054. doi: 10.1210/ jc.2005-0304
52. Iranmanesh A (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73:1081-1088
53. Veldhuis JD (1991) Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72:51-59
54. Clasey JL (2001) Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. J Clinical Endocrinol Metab 86:3845-3852. doi: 10.1210/jc.86.8.3845
55. Corneli G (2005) The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 153:257-264. doi: 10.1530/eje.1.01967